Peters Ulrike, Frenzel Karsten, Brettschneider Reinhold, Oldenburg Marcus, Bittner Cordula
Biocenter Klein Flottbek and Botanical Garden, University of Hamburg, Hamburg, Germany.
Institute for Occupational Medicine and Maritime Medicine (ZfAM), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
PLoS One. 2015 May 11;10(5):e0126455. doi: 10.1371/journal.pone.0126455. eCollection 2015.
Dust of green coffee beans is known to be a relevant cause for occupational allergic disorders in coffee industry workers. Recently, we described the first coffee allergen (Cof a 1) establishing an allergenic potential of green coffee dust.
Our aim was to identify allergenic components of green coffee in order to enhance inhalative coffee allergy diagnosis.
A Coffea arabica pJuFo cDNA phage display library was created and screened for IgE binding with sera from allergic coffee workers. Two further coffee allergens were identified by sequence analysis, expressed in E. coli, and evaluated by Western blots. The prevalence of sensitization to recombinant Cof a 1, Cof a 2, and Cof a 3 and to commercially available extract was investigated by ELISA (enzyme-linked immunosorbent assay) respectively CAP (capacity test) screening in 18 sera of symptomatic coffee workers.
In addition to the previously described chitinase Cof a 1, two Coffea arabica cysteine-rich metallothioneins of 9 and 7 kDa were identified and included in the IUIS Allergen Nomenclature as Cof a 2 and Cof a 3. Serum IgE antibodies to at least one of the recombinant allergens were found in 8 out of 18 symptomatic coffee workers (44%). Only 2 of the analysed sera (11%) had reacted previously to the commercial allergy test.
In addition to the previously described Cof a 1 we have identified two further coffee proteins to be type I coffee allergens (Cof a 2 and Cof a 3) which may have a relevant potential for the specific diagnosis and/or therapy of coffee allergy.
生咖啡豆粉尘是咖啡行业工人职业性过敏疾病的一个相关病因。最近,我们描述了首个咖啡过敏原(Cof a 1),证实了生咖啡粉尘的致敏潜力。
我们的目的是鉴定生咖啡中的致敏成分,以改进吸入性咖啡过敏的诊断。
构建了一个阿拉伯咖啡豆pJuFo cDNA噬菌体展示文库,并用咖啡过敏工人的血清筛选与IgE结合的成分。通过序列分析鉴定出另外两种咖啡过敏原,在大肠杆菌中表达,并通过蛋白质印迹法进行评估。分别通过酶联免疫吸附测定(ELISA)和CAP(能力检测)筛选,在18例有症状的咖啡工人血清中研究了对重组Cof a 1、Cof a 2和Cof a 3以及市售提取物的致敏率。
除了先前描述的几丁质酶Cof a 1外,还鉴定出两种分子量分别为9 kDa和7 kDa的富含半胱氨酸的阿拉伯咖啡豆金属硫蛋白,并被国际免疫学会过敏原命名委员会列为Cof a 2和Cof a 3。18例有症状的咖啡工人中有8例(44%)血清中发现了针对至少一种重组过敏原的IgE抗体。在分析的血清中,只有2例(11%)先前对商业过敏试验有反应。
除了先前描述的Cof a 1外,我们还鉴定出另外两种咖啡蛋白为I型咖啡过敏原(Cof a 2和Cof a 3),它们可能在咖啡过敏的特异性诊断和/或治疗中具有重要潜力。